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Introduction
Labour induction is a process of artificial stimulation of uterine 
contractions before the spontaneous onset of natural labour with 
the aim to achieve a vaginal delivery. It is one of the most common 
obstetric interventions, occurring in up to 30% of pregnancies.1–3 In 
2004 and 2005, one in every five deliveries in the UK was induced.
The most common method of labour induction when the status 
of the cervix is unfavourable involves intravaginal insertion of 
prostaglandin, whereas when the cervix is ripe, oxytocin may be 
administered intravenously.4,5
The use of induction among nulliparous women is of particular 
interest, where induction is six times more likely to fail than in 
multiparous women.7–9 Moreover, induced delivery could be 
associated with instrumental births (15% of cases) and emergent 
caesarean sections (22% of cases).3,6
Aim of study was to know perinatal outcomes according to method 
used for labor induction. 
Materials and methods
Cross-sectional descriptive study from January 2012 to December 
2012. Our population was 530 women that required labour induction 
according to common, routine indications and after being informed, 
written consent was obtained.
There were women who were eligible for labour induction with 
prostaglandins, others after the second day of induction with a new 
dose of prostaglandins depending on the Bishop Test score, and in 
other cases, if the cervix had changed or was favourable within the 
first day or two, induction with oxytocin was performed.
We created 7 groups. Group A started the induction with 10 mg 
of vaginal dinoprostone and they gave birth during that day. Group 
B started with 10 mg of vaginal dinoprostone, but the second day 
they needed another dose of 10 mg of vaginal dinoprostone. Group C: 
started with 10 mg of vaginal dinoprostone but for 24 hours the cervix 
was favourable and women continued the induction with oxytocin 
intravenously until the childbirth. Group D started with 10mg of 
vaginal dinoprostone the first day, the second they received another 
dose of 10mg of dinoprostone, and if the cervix was favourable 
oxytocin was administered. Group E started with 10mg of vaginal 
dinoprostone and continued with oxytocin the second day. Group F 
started with 10 mg of vaginal dinoprostone the first day, the second 
day they needed another dose of dinoprostone, and the third day they 
continued with oxytocin until the childbirth. Group G: started with 
oxytocin from the first day, either because the cervix was unfavourable 
(Bishop Score ≥6), there was a risk of uterine hyperstimulation or 
because there were contraindications to administer prostaglandins.
The inclusion criteria were pregnancy with one or more of 
the common indications for labour induction, including post term 
pregnancy (41 weeks and three days in our study), premature rupture 
of membranes (24 hours of evolution), pre-eclampsia or higher blood 
pressure, oligohydramnios, hepatic cholestasis, diabetes, Intrauterine 
growth restriction, chorioamnionitis or causes of maternal and foetal 
interest. 
Exclusion criteria were twin induction, induction of dead foetus, 
two previous caesarean sections or an incomplete clinical history.
 A comparison between the different options of intervention was 
performed using the Chi-Square Test. In some cases, the probability 
of an event related to an exposure was calculated using percentages 
and the relative risk (RR). The SPSS 15.0 software programme was 
used for statistical analysis.
Results
A total of 530 women were included in the study and all of them 
underwent induced labour. The weeks of pregnancy were between 32 
and 42 weeks, with an average of 40 weeks and a standard deviation 
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Abstract
Background and Purpose: To evaluate the use of prostaglandins and oxytocin in labour 
induction according to different indications. Perinatal outcomes, rate of vaginal delivery 
and complation of labour were studied and compared. 
Methods: Cross-sectional descriptive study from January 2012 to December 2012. 530 
women who required labour induction were included. Seven groups were created according 
to the methods of induction. Women with twin pregnancies, induction of dead foetus, two 
previous caesarean sections or an incomplete clinical history were excluded. 
Results: The rate of vaginal deliveries in women that only received prostaglandins the 
first day was 84.6%; similar in women with prolonged pregnancies, 85.2%. The induction 
with oxytocin directly showed the highest rate of caesarean section. The rate of vaginal 
deliveries was 50% in women with previous caesarean section. 
Conclusions: A high rate of vaginal deliveries with a single dose of prostaglandin and 
within 24 hours of beginning induction. Administration of prostaglandins must be used 
when cervix is unfavorable and previous to oxytocin stymulation.
Keywords: labour induction, vaginal dinoprostone, prostaglandin, oxytocin, cervical 
ripening and vaginal delivery
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of 1.6. The result of induction was: 26.4% caesarean sections, 60.9% 
normal deliveries and 12.6% instrumental deliveries (a total of 73.6% 
of vaginal deliveries). Among them, there were 308 nulliparous, 174 
with previous vaginal deliveries and 48 with previous caesarean 
section. Table 1 shows the rate of vaginal deliveries and caesarean 
section according to the methods of induction. We can see in Table 
2 the rate of vaginal deliveries and caesarean section according to 
the weeks of pregnancy. In week 39 there is a higher rate of vaginal 
deliveries in woman with term labour, 84.3%; while with women with 
pre-term birth we attain 100% of vaginal delivery in week 34 and 80% 
in week 35, although we have a small sample size in these weeks. 
Table 1 The rate of vaginal deliveries and caesarean section according to the methods of induction
Different treatments Total Vaginal delivery Caesarean section
A: Prostaglandins 1st day 234 198 (84.6%) 36 (15.4%)
B: Prostaglandins 1st + 2nd day 68 55 (80.9%) 13 (19.1%)
C: Prostaglandins 1st day + Oxytocin 1st day 10 8 (80%) 2 (20%)
D: Prostaglandins 1st and 2nd day + Oxytocin 2nd day 8 5 (62.5%) 3 (37.5%)
E: Prostaglandins 1st day + Oxytocin 2nd day 58 34 (58.6%) 24 (41.4%)
F: Prostaglandins 1st and 2nd day + Oxytocin 3rd day 131 80 (61.1%) 51 (38.9%)
G: Oxytocin 1st day 21 10 (47.6%) 11 (52.4%)
Total 530 390 140
Table 2 The rate of vaginal deliveries and caesarean section according to the weeks of pregnancy
Weeks 32 33 34 35 36 37 38 39 40 41
Vaginal delivery  1 (50%) 0 (0%) 6 (100%) 4 (80%) 4 (66.6%) 15 (78.9%) 52 (78.7%) 70 (84.3%) 66 (70.9%) 172 (66%)
Caesarean section 1 1 0 1 2 4 14 13 27 77
Total 2 1 6 5 6 19 66 83 93 249
If we calculate the rate of vaginal deliveries in women treated 
with prostaglandins for one day as opposed to women with other 
treatments, we can see that the rate of vaginal deliveries in women 
that only received prostaglandins the first day was 84.6%, whereas 
in women who received other types of treatment the rate was 64.9% 
(RR=1,3), that is a significant difference (Chi-Square Test 0,001).
When the rate of vaginal deliveries using prostaglandins two 
days and oxytocin the third day was calculated, the rate of vaginal 
deliveries was 61.1%, so it was lower than the rate obtained with 
other treatments, which was 77.7% (RR=1.27); This reduction shows 
a significant difference (Chi-Square Test <0,03).
We have determined the rate of vaginal delivery taking into 
account the reason for induction (Table 3).
We can observe that induction due to pre-labour rupture of 
membranes show a difference of 57 points between the rate of vaginal 
deliveries and the rate of caesarean section, followed by induction 
due to intrauterine growth restriction (a 54.6 point difference) and 
oligohydramnios (50.8 points). Whereas, if we divide the total of 
induction according to the final result, we can see that the largest 
percentage of vaginal deliveries is obtained when induction is 
indicated due to prolonged pregnancy. This is because there are more 
cases of induction due to prolonged pregnancy (41.7%) compared to 
other causes, but it shows a difference of 40.2 points between the rate 
of vaginal deliveries and caesarean section.
The most frequent cause of induction is prolonged pregnancy, with 
221 women. We need to turn our attention to this group in order to 
improve the rate of vaginal delivery. In Table 4 we show the rate of 
vaginal delivery in prolonged pregnancy (41 weeks and 3 days in our 
study), with 70.1% of vaginal delivery. We observe that most success 
is obtained in women that only received prostaglandins the first day, 
and the failure of the oxytocin as the only treatment.
Table 3 The rate of vaginal delivery taking into account the reason for induction
Cause of induction Total Vaginal delivery Caesarean section
Prolonged pregnancy 221 (41o7%) 155 (70.1%) 66(29.9%)
PRM 158 (29.8%) 124 (78.5%) 34 (21.5%)
Higher blood pressure 24 (4.5%) 15 (62.5%) 9 (37.5%)
Oligohydramnios 65 (12.3%) 49 (75.4%) 16 (24.6%)
Hepatic cholestasis 7 (1.3%) 7 (100%) -
Intrauterine Growth Restriction 44 (8.3%) 34 (77.3%) 10 (22.7%)
Foetal interest 5 (0.9%) 3 (60%) 2 (40%)
Chorioamnionitis 1 (0.2%) - 1 (100%)
Others 5 (0.9%) 3 (60%) 2 (40%)
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Table 4 The rate of vaginal deliveries and caesarean section in prolonged pregnancies
Total Vaginal delivery Caesarean Section
A: Prostaglandins 1st day 87 (85.2%) 15 (14.7%)
B: Prostaglandins 1st + 2nd day 20 (80%) 5 (20%)
C: Prostaglandins 1st day + Oxytocin 1st day 3 (75%) 1 (25%)
D: Prostaglandins 1st and 2nd day + Oxytocin 2nd day 2 (40%) 3 (60%)
E: Prostaglandins 1st day + Oxytocin 2nd day  16 (59.2%) 11 (40.7%)
F: Prostaglandins 1st and 2nd day + Oxytocin 3rd day 26 (40.6%) 28 (59.3%)
G: Oxytocin 1st day  1 (25%) 3 (75%)
Total 221 155 (70.1%) 66 (29.8%)
We compared the vaginal delivery rate in nulliparous and 
multiparous women submitted to labour induction. We obtained 
in multiparous women; a 93.1% rate of vaginal deliveries while in 
nulliparous women, the rate of vaginal deliveries was 66.2%. The rate 
of vaginal deliveries in women with previous caesarean section is low, 
with 50% of vaginal deliveries.
If we show the finalization of delivery in nulliparous women we 
can see that the rate of instrumental births is 76.1% in comparison 
to 23.9% observed in multiparous women (RR=3.18). The same 
happened with the caesarean section, that was observed in 74.6% of 
nulliparous and in a 25.7% of multiparous women (RR=2.9).
Perinatal results depend on the reason of previous caesarean 
section (Table 5).
We also determine the different types of induction in women with 
previous caesarean section. The method most frequently used was to 
administer prostaglandins the first day (Group A), 68.4% of vaginal 
deliveries were obtained. Group of treatment A and B achieved the 
highest rate of vaginal deliveries in women with previous caesarean 
section (68.4% and 75% respectively). 
Table 5 Finalization of delivery in women with previous caesarean section
Prior caesarean section due to: Vaginal delivery Caesarean section
No Progression/Failed induction 15 (31, 25%) 5 10
Cephalopelvic Disproportion 7 (14, 6%) 4 3
Losing Fetal Wellbeing 9 (18, 7%) 4 5
Other causes 17 (35, 4%) 11 6
We can observe that among cases receiving oxytocin the second 
day or the first day directly, as the cervix was favourable (Bishop 
Score ≥6), the rate of caesarean section was greater; with 83.3% 
when we administered the treatment Group E, and 61.5% when we 
administered the treatment Group F, and 66.6% when we administered 
oxytocin directly without prior prostaglandin (Group G). 
We determined the influence of the Bishop Test Score in the rate 
of vaginal deliveries. The results obtained are that if the Bishop Test 
Score on the first day of induction was greater than 4, the rate of 
vaginal delivery was 73.8%, in comparison to the 70.7% (RR=1.04) 
observed when the Bishop Test Score was 4 or less; although this 
difference was not statistically significant.
On the second day of induction, if the Bishop Test Score was greater 
than 4, the rate of vaginal deliveries was 69.8%, in comparison to the 
63.7% (RR=1,09) observed if the Bishop Test Score was 4 or less, 
but no significant difference was found. However, when the Bishop 
Test Score was calculated on the third day of induction, it was found 
that if the score was greater than 4, the rate of vaginal deliveries was 
81.3%, but when it was 4 or less, the rate of vaginal deliveries was 
45.5% (RR=1.78); and that this difference was statistically significant 
(Chi-Square Test <0,04).
Out of 530 births, it was possible to calculate postpartum pH in 
498 cases. The average was 7.28 with a standard deviation of 0.085; 
which is within the normal range.
Discussion
Although the rate of vaginal delivery is higher than 70%, in post-
term labour in week 41, the rate declines by up to 66%. The rate of 
caesarean section in the inductions of our study was 26.4%; this is 
acceptable taking into account other studies. In this study the rate of 
instrumental deliveries was 12.6% of total inductions (17.2% of all 
vaginal deliveries). According to a study in the UK,3 labour induction 
is associated with 15% of instrumental births and 22% of caesarean 
deliveries.
According to similar studies, oxytocin without prior administration 
of prostaglandins is the method with the highest rate of caesarean 
section when women have unfavourable cervix.10 Vaginal or oral 
misoprostol could improve Bishop score in this patients.11 In this 
sense, oral misoprostol seems to have a lower rate of caesarean 
section.12 Moreover time to delivery is lower with oral misoprostol.13
We obtain similar results when we analyse only prolonged 
pregnancies, which is the main cause of labour induction. Three 
trials.11 including 260 women reported that oxytocin was associated 
with more failures in achieving vaginal delivery within 24 hours than 
vaginal prostaglandin E2.
In this study, we decided to treat with oxytocin directly when 
there was no contraindication to prostaglandins, if the cervix was 
considered favourable or if the Bishop Test score was 6 or more. 
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However, NICE guidelines do not support the use of intravenous 
oxytocin alone for labour induction. In clinical practice, in the case 
of ruptured membranes, intravenous oxytocin is often recommended 
as an alternative initiating agent to prostaglandins.3 Moreover, WHO 
recommends that when prostaglandins are not available, intravenous 
oxytocin alone should be used for labour induction.14 Both guidelines 
acknowledge that there is a higher chance of vaginal birth within 24 
hours with the use of prostaglandins as opposed to oxytocin alone.
A different group is women with premature rupture of membranes. 
In a systematic review15 was included 240 women that compared 
oxytocin to vaginal prostaglandin E2 for premature rupture of 
membranes at term; in this study, oxytocin was associated with a 
significantly shorter time from induction to delivery (3.4 +/- 1.5 versus 
9.6 +/- 4.7 hours; p = 0.02). In our study there was no difference in the 
risk of caesarean section.
In our study, the induction in nulliparous women was more frequent 
than in multiparous, with a rate of 58.1% and 32.8% respectively 
(RR=1.77). In the case of previous caesarean delivery, the rate was 
only 9.1% of total labour inductions. There are other studies that 
conclude that labour induction in nulliparous with unfavourable 
cervix results in high caesarean delivery rates.16,17
It is necessary to emphasize that the efficacy of prostaglandins 
(dinoprostone) is also demonstrated in cases of previous caesarean 
section, obtaining high rates of vaginal deliveries, such as 68.4% in 
cases of prostaglandins for the first day, 75% in cases of prostaglandins 
for the first and second days, and 100% when prostaglandins and 
oxytocin were received the first day. However, it should be recognized 
that the sample is very unrepresentative. 
In women with Bishop score <7 mechanical methods could also be 
helpful. Double balloon catheter or Foley cather are safe and decrease 
the rate of unfovourable cervix.18,19 
It could be interesting to know which the cost associatted to labour 
induction are. According to some studies misoprostol decrease time to 
delivery and for this reason the cost comparated with double balloon 
catheher or dinoprostone is lower. 
We acknowledge the limitations of the study, such as the wide range 
of gestation weeks and the induction in different types of pregnancies, 
such as prolonged pregnancies, preterm rupture of membranes and 
preeclampsia, among others, that are all complicated pregnancies. 
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